| Literature DB >> 24188964 |
Rachel Jenkins1, Caleb Othieno, Stephen Okeyo, Dan Kaseje, Julyan Aruwa, Henry Oyugi, Paul Bassett, Felix Kauye.
Abstract
TRIALEntities:
Year: 2013 PMID: 24188964 PMCID: PMC4174904 DOI: 10.1186/1752-4458-7-25
Source DB: PubMed Journal: Int J Ment Health Syst ISSN: 1752-4458
Figure 1Flow chart of trial.
Characteristics of clinics
| Clinic attendance > 100/wk (*) | 24 (65%) | 17 (45%) | 0.17 (0.16, 1.10) | 0.08 |
| Antipsychotic present (†) (*) | 7 (18%) | 3 (8%) | 0.37 (0.10, 1.44) | 0.16 |
| Antidepressant present (†) (*) | 6 (15%) | 4 (10%) | 0.61 (0.17, 2.22) | 0.47 |
| Benzodiazepine present (†) (*) | 10 (27%) | 21 (54%) | 3.15 (1.22, 8.13) | 0.02 |
| Antiepileptic present (†) (*) | 16 (42%) | 12 (30%) | 0.59 (0.23, 1.48) | 0.27 |
(†) Present defined as drugs fully present.
(*) Number (%) presented for each group. Differences between groups presented as odds ratio.
Sociodemographic characteristics of selected group of 12 patients per clinic
| Female (*) | 361 (76%) | 329 (73%) | 0.81 (0.52, 1.24) | 0.36 |
| Age (continuous) (**) | 32.8 (13.2) | 34.6 (14.5) | 1.7 (−0.6, 4.0) | 0.16 |
| Age 36+ (*) | 89 (38%) | 242 (35%) | 1.37 (0.99, 1.90) | 0.06 |
| Single/Divorced/Widowed (*) | 83 (18%) | 122 (27%) | 1.87 (1.22, 2.87) | 0.004 |
| Not Luo tribe (*) | 24 (5%) | 14 (3%) | 0.69 (0.14, 2.49) | 0.64 |
| 4+ children (*) | 199 (42%) | 191 (42%) | 1.01 (0.72, 1.43) | 0.95 |
| Left education aged 17+ (*) | 201 (44%) | 172 (40%) | 0.88 (0.61, 1.26) | 0.47 |
(*) Number (%) presented for each group. Differences between groups presented as odds ratio.
(**) Mean (SD) presented for each group. Mean difference between groups also reported.
GHQ rate of accurate identification of mental disorder by health workers in the clinics
| Intention to treat analysis | Zero non-zero | 36 (100%) 0 (0%) | 38 (95%) 2 (5%) | 0.50 |
| Per protocol analysis | Zero non-zero | 33 (100%) 0 (0%) | 38 (95%) 2 (5%) | 0.50 |
Recovery of clients
| GHQ | Baseline | 463 | 5.80 (2.37) | 447 | 6.73 (2.38) | 0.92 (0.24, 1.60) | |
| | Follow-up | 463 | 5.61 (2.58) | 447 | 5.33 (2.66) | −0.30 (−1.08, 0.48) | 0.45 |
| | Change (*) | 463 | −0.48 | 447 | −1.11 | −0.63 (−1.27, 0.01) | 0.05 |
| EQ | Baseline | 447 | 0.66 (0.19) | 438 | 0.63 (0.20) | −0.04 (−0.08, 0.01) | 0.09 |
| | Follow-up | 447 | 0.66 (0.25) | 438 | 0.72 (0.19) | 0.06 (0.01, 0.11) | |
| | Change (*) | 447 | 0.01 | 438 | 0.09 | 0.07 (0.04, 0.11) | |
| WHODAS | Baseline | 462 | 25.6 (8.9) | 437 | 29.8 (8.7) | 4.0 (1.3, 6.7) | |
| | Follow-up | 462 | 26.8 (11.6) | 437 | 25.5 (9.2) | −1.6 (−5.1, 1.8) | 0.36 |
| | Change (*) | 462 | 0.1 | 437 | −3.1 | −3.3 (−5.8, −0.7) | |
| GHQ | Baseline | 418 | 5.80 (2.37) | 447 | 6.73 (2.38) | 0.91 (0.23, 1.60) | |
| | Follow-up | 418 | 5.79 (2.54) | 447 | 5.33 (2.66) | −0.48 (−1.26, 0.29) | 0.22 |
| | Change (*) | 418 | −0.32 | 447 | −1.12 | −0.81 (−1.45, −0.17) | |
| EQ | Baseline | 398 | 0.65 (0.19) | 438 | 0.63 (0.20) | −0.02 (−0.07, 0.02) | 0.26 |
| | Follow-up | 398 | 0.65 (0.25) | 438 | 0.72 (0.19) | 0.07 (0.02, 0.13) | |
| | Change (*) | 398 | 0.01 | 438 | 0.09 | 0.08 (0.04, 0.12) | |
| WHODAS | Baseline | 418 | 25.7 (8.9) | 437 | 29.8 (8.7) | 3.9 (1.2, 6.7) | |
| | Follow up | 418 | 27.3 (11.8) | 437 | 25.5 (9.2) | −2.2 (−5.7, 1.4) | 0.23 |
| Change (*) | 418 | 0.6 | 437 | −3.2 | −3.8 (−6.4, -1.2) | ||
(*) Assessed by analysing change in scores, adjusting for baseline scores. Marginal means presented. p values in bold all significant at <0.05, or greater (see text).
Days unable to perform activities in last month
| Unable to | Baseline | 3.5 (6.0) | 5.4 (6.5) | 1.58 (1.24, 2.01) | |
| Perform | Follow-up | 4.5 (7.8) | 2.8 (5.0) | 0.92 (0.73, 1.16) | 0.49 |
| activities | Change (*) | 0.9 (7.9) | −2.5 (7.0) | 0.81 (0.65, 1.02) | 0.08 |
(*) Ratio assessed by analysing follow-up values, adjusting for baseline values.